Revvity, Inc. (RVTY)
NYSE·Healthcare·Medical - Diagnostics & Research
$82.94
-2.63%
Mkt Cap $10.54B
Analyst Ratings
Buy
4
Hold
7
Sell
0
Price Target (23 analysts)
$115.14
Range $105.00 – $129.00
Implied Upside
+38.8%
Consensus $115.14 vs current $82.94